It was shown that IRE1α, XBP1, and GRP78 were upregulated in B-ALL patients at diagnosis and at relapse, and high levels of these proteins predicted a poor outcome [86, 87]. This evidence concerns the gene HSPA5 and precursor B-cell acute lymphoblastic leukemia.